top of page
CLDF-24-06 MASLD MASH_Wix Banner_v2.jpg

FACULTY

loomba.png

Rohit Loomba, MD, MHSc
University of California at San Diego
La Jolla, CA

gunn.png

Nadege T. Gunn, MD, CPI
Velocity Clinical Research
Waco, TX

gillies.png

HoChong Gilles, DNP, FNP-BC
Richmond VA Medical Center
Midlothian, VA

Program Overview and Target Audience:

The joint providership of University of Cincinnati College of Medicine (Cincinnati), Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) presents the Expert Perspectives on MASLD/MASH: A 2024 Liver Conference Coverage Series. The initiative will feature an accredited series of livestream meetings following major liver congresses to review and discuss emerging data presented on metabolic dysfunction-associated steatotic liver disease (MASLD) and its subtype metabolic dysfunction-associated steatohepatitis (MASH). The series will be complemented by accredited archived livestreams and educational resources on CLDF’s and GHAPP’s educational portals, chronicliverdisease.org and ghapp.org, respectively, as well as GHAPP’s mobile application, where appropriate. The initiative will target health care professionals (HCPs), including gastroenterologists, hepatologists, nurse practitioners, physician assistants, and nurses.

 

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Discuss emerging data on NIT utilization for the diagnosis and monitoring of MASH

  • Analyze current and potential pharmacologic management strategies for MASH, including GLP-1 agonists

  • Integrate weight loss into MASLD/MASH disease management strategies

 

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati, The Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Cincinnati designates this live activity a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure of Relevant Financial Relationships:

All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent relevant financial interests related to the content of the presentation or enduring material. Full disclosure of all financial relationships must be made in writing to the audience prior to the activity.

 

All additional planning committee members, the University of Cincinnati staff and The Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) staff have no relationships to disclose.

 

Planning Committee Disclosures:

Lisa Pedicone, PhD- Medical Writer

No relevant financial relationships to disclose.

Rachel Bejarano, PharmD- Medical Writer

No relevant financial relationships to disclose.

 

Learner Assurance Statement:

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

 

Disclaimer:

The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.

 

Off-Label Disclosure Statement:

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

 

Fee information: There is no fee for this educational activity.

Jointly provided by the University of Cincinnati, the Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP).

Supported by an educational grant from Novo Nordisk Inc.

GHAPP Logo.jpg
CLDF-logo.png
UC_logo-[black+red]-01.png
bottom of page